NASDAQ:ADAG

Adagene (ADAG) Stock Price, News & Analysis

Adagene logo
$1.76 -0.25 (-12.44%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$1.76 -0.01 (-0.28%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Adagene Stock (NASDAQ:ADAG)

Advanced

Key Stats

Today's Range
$1.35
▼
$2.05
50-Day Range
$1.48
▼
$3.37
52-Week Range
$1.27
▼
$4.85
Volume
1.37 million shs
Average Volume
426,558 shs
Market Capitalization
$116.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.25
Consensus Rating
Moderate Buy

Company Overview

Adagene Inc. is a clinical-stage biotechnology company focused on discovering and developing antibody-based cancer immunotherapies. Its research combines computational protein-design methods with antibody engineering to create treatments intended to target tumors and engage the immune system.

The company’s technologies include its SAFEbody platform, which is designed to keep an antibody’s activity masked until it reaches the tumor environment. Adagene is also developing antibody candidates that target immune-regulatory pathways, including CTLA-4, for potential use in cancer treatment.

Founded in 2011, Adagene has operations in China and the United States and pursues drug development for international markets. Co-founder Peter Luo has served as the company’s chief executive officer.

AI Generated. May Contain Errors.

Adagene Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
62nd Percentile Overall Score

ADAG MarketRank™: 
3.12210850974 of 5 stars

Adagene scored higher than 62% of companies evaluated by MarketBeat, and ranked 289th out of 837 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Adagene has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 3 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    Adagene has a consensus price target of $8.25, representing about 368.8% upside from its current price of $1.76.

  • Amount of Analyst Coverage

    Adagene has only been the subject of 3 research reports in the past 90 days.

  • Read more about Adagene's stock forecast and price target.
  • Earnings Growth

    Earnings for Adagene are expected to grow in the coming year, from ($0.50) to ($0.45) per share.

  • Price to Book Value per Share Ratio

    Adagene has a P/B Ratio of 2.35. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    4.18% of the float of Adagene has been sold short.
  • Short Interest Ratio / Days to Cover

    Adagene has a short interest ratio ("days to cover") of 11.83, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Adagene has recently increased by 2.70%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Adagene does not currently pay a dividend.

  • Dividend Growth

    Adagene does not have a long track record of dividend growth.

  • News Sentiment

    Adagene has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Adagene this week, compared to 2 articles on an average week.
  • Cluster Insider Buying

    2 insiders have purchased shares of Adagene in the last three months. Multiple insiders buying is a strong bullish signal.

  • Net Insider Buying

    Over the last three months, insiders have purchased a net $69,914.00 in company stock, which represents 0.0601% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Adagene insiders have bought more of their company's stock than they have sold. Specifically, they have bought $69,914.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    21.20% of the stock of Adagene is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    9.51% of the stock of Adagene is held by institutions.

  • Read more about Adagene's insider trading history.
Receive ADAG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adagene and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ADAG Stock News Headlines

Wall Street Zen Upgrades Adagene (NASDAQ:ADAG) to "Hold"
Prediction: NVDA will “snap back” on this date
Others paid $500 for the Snapback Indicator. For Black Friday, Base Camp Trading is offering lifetime access for just $7. The specialized indicator shows when a stock is likely to "snap back," helping traders avoid buying at the peak. It can also flag when a stock may bounce off the bottom so you can time your entry. Run NVDA or any other popular AI stock through it before you place a trade.tc pixel
See More Headlines

ADAG Stock Analysis - Frequently Asked Questions

Adagene's stock was trading at $1.89 on January 1st, 2026. Since then, ADAG stock has decreased by 6.9% and is now trading at $1.76.

Adagene Inc. Sponsored ADR (NASDAQ:ADAG) issued its quarterly earnings results on Wednesday, April, 1st. The company reported ($0.04) earnings per share for the quarter, topping analysts' consensus estimates of ($0.28) by $0.24. The company earned $3.84 million during the quarter, compared to analysts' expectations of $17.50 million.

Adagene (ADAG) raised $132 million in an IPO on Tuesday, February 9th 2021. The company issued 7,354,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs (Asia), Morgan Stanley and Jefferies acted as the underwriters for the IPO and China Renaissance was co-manager.

Top institutional shareholders of Adagene include Flputnam Investment Management Co. (1.03%), Marshall Wace LLP (0.68%) and State Street Corp (0.04%). Insiders that own company stock include Peter Luo and Man Kin Tam.
View institutional ownership trends
.

Shares of ADAG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Adagene investors own include Advanced Micro Devices (AMD), Plug Power (PLUG), Skillz (FIRY), NIO (NIO), Allogene Therapeutics (ALLO), Blink Charging (BLNK) and CRISPR Therapeutics (CRSP).

Company Calendar

Today
11/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ADAG
CIK
1818838
Fax
N/A
Employees
128
Year Founded
2012

Price Target and Rating

High Price Target
$10.00
Low Price Target
$7.00
Potential Upside/Downside
+368.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
5.02
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$9.29 million
Price / Sales
12.51
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.75 per share
Price / Book
2.35

Miscellaneous

Outstanding Shares
66,052,000
Free Float
52,049,000
Market Cap
$116.25 million
Optionable
Not Optionable
Beta
0.69

Social Links

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:ADAG) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners